US Patent Issued to 1GLOBE BIOMEDICAL on March 25 for "Combination solution for treating chemotherapy refractory cancer" (Massachusetts Inventor)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,227, issued on March 25, was assigned to 1GLOBE BIOMEDICAL Co. LTD. (Beijing).

"Combination solution for treating chemotherapy refractory cancer" was invented by Chiang J. Li (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The use of a pharmaceutical composition in treating cancer in a subject comprising a therapeutically effective amount of a compound of formula (I), a therapeutically effective amount of paclitaxel and a low dose of gemcitabine, and a kit included above composition thereof."

The patent was filed on Oct. 12, 2019, under Application No. 17/284,654.

*For further information, including images, charts and tables, ple...